bucladesine has been researched along with Burkitt Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatano, Y; Hirokawa, M; Kitabayashi, A; Kuroki, J; Lee, M; Miura, AB; Niitsu, H | 1 |
1 other study(ies) available for bucladesine and Burkitt Lymphoma
Article | Year |
---|---|
Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production.
Topics: Antibodies, Monoclonal; Bucladesine; Burkitt Lymphoma; Cyclic AMP; Cytotoxicity, Immunologic; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Lymphocyte Activation; Pentoxifylline; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |